Navigation Links
Kincannon & Reed Promotes Jon Leafstedt to Managing Partner
Date:9/22/2010

DES MOINES, Iowa, Sept. 22 /PRNewswire/ -- Kincannon & Reed, a leading global executive search firm focused on the food, agribusiness, and life sciences sectors, today announced the promotion of Jon Leafstedt to Managing Partner.  

In his new role, Leafstedt will focus on expanding the firm's client base in North America and its global marketing strategies.  He will continue to be responsible for senior-level executive searches in all areas of the business with particular emphasis in biotechnology, seed, crop protection products, animal health, and renewable fuels.  

Prior to joining Kincannon & Reed in 2007 as a principal, Leafstedt served in wide-ranging executive roles in global agribusinesses and development-stage technology companies, including serving as president of Chromatin, Inc., a plant biotechnology firm.  

"Jon's broad executive experiences in our target industry sectors and excellent track record as a principal at Kincannon & Reed are tremendous assets to our firm and the many clients we serve," said Greg Duerksen, President of Kincannon & Reed.  "His leadership will be instrumental in the continued development and growth of our firm in North America."  

Leafstedt has been a leader in national and state industry associations, including Animal Health Institute, CropLife America, American Feed Industry Association, and Iowa Biotechnology Association.  He serves on the Board of the Iowa Corn Opportunities Fund, a venture capital fund managed by the Iowa Corn Growers Association.  He earned his MBA from the University of Iowa and a BS degree in Animal Science from South Dakota State University.  

Kincannon & Reed (www.krsearch.com) is the only retained global executive search firm focused exclusively on the food, agribusiness, and life sciences sectors.  Founded in 1981, the company serves clients throughout the world from its offices in the Americas, Europe, and Asia / Pacific.

Media Contact:  Ellen von Fange, 540-941-8331

http://www.krsearch.com


'/>"/>
SOURCE Kincannon & Reed
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Commends Isobionics for Technology Innovation
2. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
3. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
4. NeoStem to Present at Rodman & Renshaws 12th Annual Healthcare Conference
5. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
6. Kendle to Present at Robert W. Baird & Co. 2010 Health Care Conference
7. Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference
8. Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
9. The Female Health Company to Present at Rodman & Renshaws Annual Global Investment Conference on Wednesday, September 15, 2010
10. IGEN Networks Corp. obtains Blue Sky Statutory Compliance in 38 States with Approval of Standard & Poors
11. Uckele Health & Nutrition Ranks on the 2010 Inc. 5000 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... 03, 2016 , ... Microbial genomics leader uBiome is awarding ... been made to Dr. Renato Polimanti of Yale University School of Medicine, who ... Grant proposals have been vetted by the company’s scientific review committee. , ...
(Date:12/2/2016)... ... 2016 , ... In anticipation of AxioMed’s exclusive cleanroom manufacturing ... President, Jake Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski ... and Zurich to discuss the benefits of a viscoelastic disc. AxioMed received CE ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
(Date:12/2/2016)... ... 2016 , ... ACEA Biosciences, Inc. announced today that it will be presenting ... the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... trials for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR ...
Breaking Biology Technology:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):